Document Detail


Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease.
MedLine Citation:
PMID:  24122427     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The prevalence of coronary artery disease (CAD) in patients with peripheral arterial disease (PAD) approaches 50%. The incidence of perioperative cardiac complications is high in patients undergoing peripheral vascular surgery (PVS). However, the long-term efficacy of coronary artery revascularization in patients with PAD prior to PVS remains controversial. We retrospectively analyzed the long-term outcomes of 114 patients who underwent elective PVS. Coronary angiography (CAG) was performed routinely in all patients prior to the surgery. Preoperative CAG revealed CAD in 52 patients and no CAD in 62 patients (No-CAD group). Of the 52 patients with CAD, 15 patients with effort angina (more than CCS class 2), myocardial ischemia proven by pharmacological stress scintigraphy, and/or multivessel disease with impaired left ventricular systolic function underwent coronary revascularization (CAD-R group). The remaining 37 patients with CAD were treated medically (CAD-M group). The rates of postoperative events within 30 days were 26.7% in the CAD-R group, 10.8% in the CAD-M group, and 8.1% in the No-CAD group, respectively (P = 0.13), and the rates of long-term cardiovascular events were 33.3, 21.6, and 21.0%, respectively (P = 0.60). Therefore, the acute and long-term clinical outcomes in the CAD-R group were comparable with the other groups. In this study, the patients with CAD who showed inducible myocardial ischemia and/or multivessel disease with impaired left ventricular systolic function underwent coronary artery revascularization prior to the elective PVS. The patients who underwent coronary revascularization prior to the PVS exhibited comparable long-term outcomes compared with the patients who showed CAD but without inducible myocardial ischemia and with those without CAD. These data suggest that the evaluation of CAD and myocardial ischemia to determine the therapeutic strategy for CAD before elective PVS would be needed.
Authors:
Hideki Miyachi; Jun Tanabe; Eitaro Kodani; Yusuke Hosokawa; Mitsunobu Kitamura; Asako Sasaki; Michio Ogano; Kunito Shiiba; Hisato Takagi; Takuya Umemoto; Yoshiki Kusama; Kyoichi Mizuno
Related Documents :
3338127 - New diagnostic evidence on the t wave map indicating involved coronary artery in patien...
23882287 - Assesment of myocardial ischemia by combination of tissue synchronisation imaging and d...
2037747 - The frequency and significance of ecg changes after transurethral prostate resection.
22154907 - Cardioprotection requires flipping the 'posttranslational modification' switch.
20580517 - Utilization of emergency medical services by patients with acute coronary syndromes in ...
22229967 - Association studies of gene polymorphisms in toll-like receptors 2 and 4 in croatian pa...
Publication Detail:
Type:  Journal Article     Date:  2009-11-12
Journal Detail:
Title:  Cardiovascular intervention and therapeutics     Volume:  25     ISSN:  1868-4300     ISO Abbreviation:  Cardiovasc Interv Ther     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2013-10-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101522043     Medline TA:  Cardiovasc Interv Ther     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  11-7     Citation Subset:  -    
Affiliation:
Division of Cardiology, National Hospital Organization Shizuoka Medical Center, Shizuoka, Japan, hidep-@nms.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Optical coherence tomography imaging: current status and future perspectives : Current and future de...
Next Document:  Low responsiveness to thienopyridine in hemodialysis patients.